Exploring therapeutic mechanisms of San-Huang-Tang in nonalcoholic fatty liver disease through network pharmacology and experimental validation
Bibliographic Data
| ID | 14740310 |
|---|---|
| Authors | Huilian Shi (0000-0003-2437-2573, Nanjing University of Chinese Medicine), Fei Qiao (0000-0002-5322-4847, Nanjing University of Chinese Medicine), Kaiyue Huang (Nanjing Medical University), Weiting Lu (0000-0002-1149-7003, Jiangsu Province Hospital), Xinzhuang Zhang (0000-0002-0833-6751, Kanion Pharmaceutical (China)), Zhipeng Ke (0000-0002-3396-8857, Kanion Pharmaceutical (China)), Yanchi Wu (0000-0002-5660-5258, Nanjing Medical University), Liang Cao (0000-0002-6569-3771, Nanjing University of Chinese Medicine, corresponding author), Yuanyuan Chen (0009-0004-1012-8646, Nanjing Medical University, corresponding author) |
| Year | 2022 |
| Volume | 296 |
| Pages | 115477 |
| Publication date | 2022-10-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Journal of Ethnopharmacology (JOURNAL) |
| Journal identifiers | ISSN: 0378-8741 • E-ISSN: 1872-7573 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.jep.2022.115477 |
| PMID | 35764198 |
| OpenAlex | W4283515530 |
| Language | EN |
| Citations received | 1 |
| References cited | 35 |
Bioinformatics · Biological pathway · Biology · Disease · Fatty liver · FOXO1 · Gene · Gene expression · Gene ontology · In vivo · Insulin · Insulin receptor · Insulin resistance · IRS1 · KEGG · Nonalcoholic fatty liver disease · Protein kinase B · Signal transduction · Bioinformatics and Genomic Networks · Liver Disease Diagnosis and Treatment · Medicine · Metabolomics and Mass Spectrometry Studies · Biochemistry · Genetics · Internal Medicine · Pharmacology
A simple practice guide for dose conversion between animals and human
Kegg
STRING v11
Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism
San-Huang-Tang protects obesity/diabetes induced NAFLD by upregulating PGC-1α/PEPCK signaling in obese and galr1 knockout mice models
| Unique citing works | 1 |
|---|---|
| Citations per year | 1 |
| Citation span | 2025 - 2025 (1) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 1 |